Skip to main content
Register
Mobile App
Browse Schedule
Full Schedule
Browse by Track
Browse by Session Type
Keyword Search
Browse by Poster Abstract
Browse by Poster Number
Browse by Poster Title
Browse by Presenter
Browse by Track
Browse by SubTrack
Solution Center
Browse by Company
Browse by Track
Browse by Booth Number
Floorplan
Visit The Solution Center
Networking Activities
Healthy Start
Philanthropy
Reception
Affiliate Event
Community Social
People
Speakers
Attendees
Sponsors
Hotels
Conference Proceedings
Login required
My Schedule
Login required
Evaluation/Surveys
Login required
Login
Toggle navigation
Home
Register
Mobile App
Browse Schedule
Full Schedule
Browse by Track
Browse by Session Type
Keyword Search
Browse by Poster Abstract
Browse by Poster Number
Browse by Poster Title
Browse by Presenter
Browse by Track
Browse by SubTrack
Solution Center
Browse by Company
Browse by Track
Browse by Booth Number
Floorplan
Visit The Solution Center
Networking Activities
Healthy Start
Philanthropy
Reception
Affiliate Event
Community Social
People
Speakers
Attendees
Sponsors
Hotels
Conference Proceedings
Login required
My Schedule
Login required
Evaluation/Surveys
Login required
Conference Brochure
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Preclinical Development
Bioanalytics
Clinical Pharmacology
Manufacturing and
Bioprocessing
Formulation and Quality
Events Networking
Partner Presentation-
Bioanalytics
Partner Presentation-
Clinical Pharmacology
Partner Presentation-
Formulation
Partner Presentation-
Preclinical
Rapid Fire Bioanalytics
Rapid Fire Clinical
Pharmacology
Rapid Fire Formulation
Rapid Fire Manufacturing &
Bioprocessing
Rapid Fire Preclinical
Bioanalytics
Type here to filter the list
Saturday, Nov 3
1:00 pm
SC4 - Introduction of Team and Objectives
Location: 146 A, WEWCC
Heather A. Myler, PhD – PPD
Saturday, Nov 3
1:00 pm
SC4 - Short Course: A Harmonized Strategy for the Regulatory Submission of Immunogenicity Validation Data
Location: 146 A, WEWCC
Heather A. Myler, PhD – PPD; An Song, PhD – Genentech; Joao Pedras-Vasconcelos, PhD – FDA-CDER-OPQ-OBP-DBRR3
Saturday, Nov 3
1:10 pm
SC4 - OBP Immunogenicity Review Challenges and Solutions
Location: 146 A, WEWCC
Joao Pedras-Vasconcelos, PhD – FDA-CDER-OPQ-OBP-DBRR3
Saturday, Nov 3
1:30 pm
SC4 - Cut Point Considerations
Location: 146 A, WEWCC
Viswanath Devanarayan, PhD, FAAPS – Charles River Laboratories
Saturday, Nov 3
3:15 pm
SC4 - Defining Assay Sensitivity
Location: 146 A, WEWCC
Kelli R. Phillips, PhD, MBA – PPD
Saturday, Nov 3
3:35 pm
SC4 - Defining Assay Drug Tolerance
Location: 146 A, WEWCC
Marta Manning, PhD – Amgen
Saturday, Nov 3
3:55 pm
SC4 - FDA Perspective on Assay Sensitivity and Drug Tolerance
Location: 146 A, WEWCC
Haoheng Yan, MD, Ph.D – FDA
Saturday, Nov 3
4:15 pm
SC4 - Defining Assay Domain Specificity/ Selectivity
Location: 146 A, WEWCC
Shobha Purushothama, Scientist – Biogen
Sunday, Nov 4
9:00 am
SC7 - Short Course: Immunogenicity Data Evaluations and Clinical Interpretation
Location: 146 A, WEWCC
Viswanath Devanarayan, PhD, FAAPS – Charles River Laboratories
Sunday, Nov 4
9:00 am
WS2 - Workshop: Bioanalytical Method Validation: The Finalized Guidance
Location: 146 C, WEWCC
Brian Booth, Ph.D.
Monday, Nov 5
8:30 am
Prologue: Bioanalytical Solutions Driving the Development of Novel Therapeutic Modalities
Location: 151 B, WEWCC
Jaya Goyal, PhD – Wave Life Sciences
Monday, Nov 5
8:30 am
Prologue: Novel Protein Modalities – Bioanalytical Challenges and Solutions
Location: 151 A, WEWCC
Yan Zhang, PhD – Bristol-Myers Squibb Company
Monday, Nov 5
9:00 am
Novel Protein Modalities – Bioanalytical Challenges and Solutions
Location: 151 A, WEWCC
Alexander Kozhich, PhD – Bristol-Myers Squibb Company
Monday, Nov 5
9:30 am
Bioanalytical Strategies for Bi-specific and Multi-specific Biologics
Location: 151 A, WEWCC
Dong Geng, PhD – Legend Biotech
Monday, Nov 5
10:00 am
Protein Misfolding and its Role in Prion Disease Expansion
Location: 151 A, WEWCC
Philip R. Oldfield, DPhil CSci CChem FRSC(UK) – Philip Oldfield Bioanalytical Consulting
Monday, Nov 5
10:30 am
Vaccine Clinical Assays: What Can We Adopt to Support Emerging Modalities?
Location: 151 A, WEWCC
Huaping Tang, PhD – Merck
Monday, Nov 5
9:00 am
LCMS/Hybridization ELISA Approaches for Bioanalysis of Stereopure Oligonucleotides
Location: 151 B, WEWCC
Susovan Mohapatra, PhD – Wave Life Sciences
Monday, Nov 5
9:00 am
Novel Therapeutic Modalities – Chemical
Location: 151 B, WEWCC
Jaya Goyal, PhD – Wave Life Sciences
Monday, Nov 5
9:30 am
Bioanalytical Challenges and Opportunities in Development of RNAi Therapeutics
Location: 151 B, WEWCC
Valerie Clausen – Alnylam Pharmaceuticals Inc.
Monday, Nov 5
10:00 am
Bioanalytical Strategies and Considerations for the Bioanalysis of Liposomal Drugs
Location: 151 B, WEWCC
Aaron Ledvina, PhD – Covance Laboratories, Inc.
Monday, Nov 5
10:30 am
Meeting Bioanalytical Challenges of Protein-Drug Conjugates with Improved Efficiency using Multiplexed Hybrid LBA-LC-MS/MS Assays
Location: 151 B, WEWCC
Morse Faria, B.Pharm., M. Pharm., PhD – PPD
Monday, Nov 5
1:30 pm
Keynote: The Expanding Frontier of Bioanalysis: New Modalities
Location: 207 B, WEWCC
Binodh DeSilva, PhD – Bristol-Myers Squibb; Brian Booth, Ph.D.
Monday, Nov 5
3:00 pm
Fighting Cancers with Oncolytic Viruses: Bioanalytical Considerations
Location: 207 A, WEWCC
LaKenya Williams, PhD – Bristol-Myers Squibb
Monday, Nov 5
3:00 pm
Immuno-Oncology: Advancement from Infancy to Products - Bioanalytical
Location: 207 A, WEWCC
Boris Gorovits – Pfizer Inc.
Monday, Nov 5
3:30 pm
Clinical Bioanalytical Strategy Consideration for Cell Therapies
Location: 207 A, WEWCC
Dong Geng, PhD – Legend Biotech
Monday, Nov 5
4:00 pm
Bi-specific T-cell Redirector PK/ADA/NAB Strategy
Location: 207 A, WEWCC
Ying Wang, Ph.D – Pfizer
Monday, Nov 5
4:30 pm
Bi-specific T-cell Redirectors: Receptor Occupancy Strategy
Location: 207 A, WEWCC
Adrienne Clements-Egan, PhD – Janssen Biotherapeutics, Janssen R&D, LLC
Monday, Nov 5
3:00 pm
Turning Multiple Assays into One: Strategic LC-MS Data Acquisition for Antibody Drug Conjugates
Location: 207 B, WEWCC
John F. Kellie, PhD, Chemistry – GSK
Monday, Nov 5
3:00 pm
Rapid and Cost-Effective Delivery of New Drugs to Patients - Bioanalytical
Location: 207 B, WEWCC
Mark E. Arnold, PhD – Covance Inc.
Monday, Nov 5
3:30 pm
Maximizing PK and PD Information from Discovery Samples
Location: 207 B, WEWCC
Timothy V. Olah, PhD – Bristol Myers Squibb Company
Monday, Nov 5
4:00 pm
Advancing Microsampling for Biomarker Analysis with Lessons Learned from Clinical Chemistry
Location: 207 B, WEWCC
Russell p. Grant, PhD – Laboratory Corporation of America
Monday, Nov 5
4:30 pm
Building Confidence in Patient Focused Precision Medicine with LC-MS Based Biomarkers and Metabolomics
Location: 207 B, WEWCC
Matthew Blatnik, PhD – Pfizer Inc.
Tuesday, Nov 6
8:30 am
Prologue: ABIRISK: Europe's IMI Immunogenicity Consortium
Location: 151 A, WEWCC
Susan M. Richards, PhD – Sanofi; Timothy Hickling
Tuesday, Nov 6
8:30 am
Prologue: New Technology and Solutions in Bioanalysis
Location: 151 B, WEWCC
Kevin Bateman, PhD – Merck & Co., Inc.; Anahita Keyhani, Ph.D. – Altasciences
Tuesday, Nov 6
9:00 am
What Could be an Achievable LC-MS/MS Sensitivity Level: Theoretical Considerations
Location: 151 B, WEWCC
Shaolian Zhou – Roche
Tuesday, Nov 6
9:00 am
New Technology and New Applications of Existing Technology - Chemical
Location: 151 B, WEWCC
Kevin Bateman, PhD – Merck & Co., Inc.; Anahita Keyhani, Ph.D. – Altasciences
Tuesday, Nov 6
9:30 am
Towards Highly Sensitive and Accurate Analysis of Novel Biotherapeutics in Tissues
Location: 151 B, WEWCC
Jun Qu, PhD – SUNY-Buffalo
Tuesday, Nov 6
10:00 am
Intact LC/MS Analysis of Peptides and Biotherapetuics for Pharmacokinetics Study
Location: 151 B, WEWCC
Naidong Weng, PhD – Janssen
Tuesday, Nov 6
10:30 am
Evaluation of Volumetric Absorptive Microsampling and its Bioanalytical Challenges
Location: 151 B, WEWCC
Jeff Plomley, M.Sc. – Altasciences Clinical Research
Tuesday, Nov 6
9:00 am
Overview of the Consortium and Major Findings
Location: 151 A, WEWCC
Marc J. Pallardy, PharmD PhD – Team leader INSERM UMR 996 Research Unit, on "Inflammation, Chemokines, & Immunopathology"
Tuesday, Nov 6
9:00 am
New Technology and New Applications of Existing Technology – Biomolecular
Location: 151 A, WEWCC
Susan M. Richards, PhD – Sanofi; Timothy Hickling
Tuesday, Nov 6
9:30 am
Understanding Mechanism of Immunogenicity including the Identification of Early Signature of ADA Response
Location: 151 A, WEWCC
Elizabeth Jury, PhD – University College London
Tuesday, Nov 6
10:00 am
Characteristics of ADA and Production of ADA Assay Standards
Location: 151 A, WEWCC
vincent Mikol, Ph.D – Sanofi
Tuesday, Nov 6
10:30 am
Clinical Observations and Genetic Associations
Location: 151 A, WEWCC
Philippe Broet, MD,PhD – University Paris-Sud/Paris-Saclay, CESP, Paris
Tuesday, Nov 6
1:30 pm
Keynote: Mass Spec Technology
Location: 151 B, WEWCC
Nathan A. Yates, PhD – University of Pittsburgh; Shaolian Zhou – Roche
Tuesday, Nov 6
1:30 pm
Keynote: State of the Art and Future Perspectives on the Predictive Immunogenicity
Location: 151 A, WEWCC
Bernard Maillère, PhD – CEA; Timothy Hickling
Wednesday, Nov 7
8:30 am
Prologue: Regulations and Science in PK, PD and ADA Analysis of Biologic Therapeutics
Location: 151 A, WEWCC
Heather A. Myler, PhD – PPD; Mark H. Ma – Alexion Pharma
Wednesday, Nov 7
8:30 am
Prologue: The Regulatory Landscape & Its Bearing on Bioanalysis
Location: 151 B, WEWCC
Mark E. Arnold, PhD – Covance Inc.; Jianing Zeng, PhD – Bristol-Myers Squibb; Faye Vazvaei, MS – Roche
Wednesday, Nov 7
9:00 am
Systematic Approaches in Investigation of Failed Bio-comparability Study
Location: 151 A, WEWCC
Mark H. Ma – Alexion Pharma
Wednesday, Nov 7
9:00 am
Emerging Regulations Impacting Bioanalysis – Biomolecular
Location: 151 A, WEWCC
Heather A. Myler, PhD – PPD; Mark H. Ma – Alexion Pharma
Wednesday, Nov 7
9:30 am
Considerations for Establishing Biosimilarity for Compounds with Observed Biotransformation
Location: 151 A, WEWCC
Kelli R. Phillips, PhD, MBA – PPD
Wednesday, Nov 7
10:00 am
Technical Approaches in Pre-study Method Validation and Sample Analysis to Minimize Bioanalytical Bias
Location: 151 A, WEWCC
Theingi Thway, PhD – FDA
Wednesday, Nov 7
10:30 am
Panel Discussion: Bioanalytical Investigation of Failed Bio-comparability Studies
Location: 151 A, WEWCC
Mark H. Ma – Alexion Pharma; Theingi Thway, PhD – FDA; Sophia Xu – BMS
Wednesday, Nov 7
9:00 am
LC-MS/MS Biomarker Assay Validation Considerations from the New Guidance: Discussion of the Upcoming AAPS Whitepaper Recommendations
Location: 151 B, WEWCC
Carmen Fernandez-Metzler, PhD – PharmaCadence Analytical Services, LLC
Wednesday, Nov 7
9:00 am
Emerging Regulations Impacting Bioanalysis – Chemical
Location: 151 B, WEWCC
Jianing Zeng, PhD – Bristol-Myers Squibb; Faye Vazvaei, MS – Roche
Wednesday, Nov 7
9:30 am
Scientific and Regulatory Considerations for the Analytical Validation of Assays Used in the Qualification of Biomarkers in Biological Matrices
Location: 151 B, WEWCC
Afshin Safavi, PhD – BioAgilytix; Steven P. Piccoli, PhD – GlaxoSmithKline
Wednesday, Nov 7
10:00 am
ICH M10 Update and the New FDA Guidance
Location: 151 B, WEWCC
Brian Booth, Ph.D.
Wednesday, Nov 7
10:30 am
Panel Discussion: Emerging Regulations Impacting Bioanalysis
Location: 151 B, WEWCC
Brian Booth, Ph.D.; Afshin Safavi, PhD – BioAgilytix; Carmen Fernandez-Metzler, PhD – PharmaCadence Analytical Services, LLC; Steven P. Piccoli, PhD – GlaxoSmithKline
Wednesday, Nov 7
1:30 pm
Keynote: Evolving Regulatory Landscape in Bioanalysis of Biologics; Immunogenicity and Biosimilars
Location: 151 A, WEWCC
Joao Pedras-Vasconcelos, PhD – FDA-CDER-OPQ-OBP-DBRR3; Boris Gorovits – Pfizer Inc.; Heather A. Myler, PhD – PPD
Wednesday, Nov 7
1:30 pm
Keynote: The Evolving Regulatory Landscape in Bioanalysis and Bioanalytical Method Validation--PK and Biomarkers
Location: 151 B, WEWCC
John Kadavil, PhD – USFDA; Faye Vazvaei, MS – Roche
Monday, Nov 5
3:00 pm
Rapid Fire Presentations: Bioanalytics – Biomolecular
Location: 151 A, WEWCC
Sumit Kar, BS – Celerion; Ashley Lay-Fortenbery – University of Kentucky; Abhisheak Sharma, M. Pharm, PhD – University of Florida
Monday, Nov 5
3:00 pm
Rapid Fire Presentations: Bioanalytics – Chemical
Location: 151 B, WEWCC
Jenny Patel – The University of Tennessee at Knoxville; Zaneera Hassan – Virginia Commonwealth University; Amr Hassan, PhD – Virginia Commonwealth University
Tuesday, Nov 6
3:00 pm
Rapid Fire Presentations: Bioanalytics – Biomolecular
Location: 151 A, WEWCC
Sreedhar Reddy Suthe, Bpharm – Texas Tech University Health Sciences Center; Mitchel Ruigrok, M.Sc. – University of Groningen; Amr Hassan, PhD – Virginia Commonwealth University
Tuesday, Nov 6
3:00 pm
Rapid Fire Presentations: Bioanalytics – Chemical
Location: 151 B, WEWCC
Sumit Kar, BS – Celerion; Swetha Thiyagarajan – North Dakota State University; Zaneera Hassan – Virginia Commonwealth University
Wednesday, Nov 7
3:00 pm
Rapid Fire Presentations: Bioanalytics – Biomolecular
Location: 151 A, WEWCC
Christopher Jay – Virginia Commonwealth University; Sreedhar Reddy Suthe, Bpharm – Texas Tech University Health Sciences Center
Wednesday, Nov 7
3:00 pm
Rapid Fire Presentations: Bioanalytics – Chemical
Location: 151 B, WEWCC
Laxmishanthi Chede, Ph.D student – University of Iowa; Preeti Dinkar Kulkarni, Dr. – Gahlot Institute of Pharmacy; Aniket Wadajkar, PhD – University of Maryland School of Medicine
Back to Top